Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

A sequence variation: 713-8delC in the transforming growth factor beta 1 gene polymorphism in thalassemia major patients.

Singh K, Agarwal S, Shukla A, Gupta S.

J Clin Densitom. 2014 Jan-Mar;17(1):185-9. doi: 10.1016/j.jocd.2013.04.004. Epub 2013 Jun 18.

PMID:
23790953
3.

Osteoporosis in beta-thalassaemia major patients: analysis of the genetic background.

Perrotta S, Cappellini MD, Bertoldo F, Servedio V, Iolascon G, D'Agruma L, Gasparini P, Siciliani MC, Iolascon A.

Br J Haematol. 2000 Nov;111(2):461-6.

PMID:
11122085
4.

Polymorphisms in the transforming growth factor beta 1 gene and osteoporosis.

Langdahl BL, Carstens M, Stenkjaer L, Eriksen EF.

Bone. 2003 Mar;32(3):297-310.

PMID:
12667558
5.

An SP1-binding site polymorphism in the COLIAI gene and osteoporosis in Egyptian patients with thalassemia major.

Hamed HM, Galal A, Ghamrawy ME, Abd El Azeem K, Hussein IR, Abd-Elgawad MF.

Blood Coagul Fibrinolysis. 2011 Mar;22(2):81-5. doi: 10.1097/MBC.0b013e32834248fb.

PMID:
21178584
7.
8.

Status of 25-hydroxyvitamin D deficiency and effect of vitamin D receptor gene polymorphisms on bone mineral density in thalassemia patients of North India.

Singh K, Kumar R, Shukla A, Phadke SR, Agarwal S.

Hematology. 2012 Sep;17(5):291-6. doi: 10.1179/1607845412Y.0000000017.

PMID:
22971535
9.

Association of T869C gene polymorphism of transforming growth factor-β1 with low protein levels and anthropometric indices in osteopenia/osteoporosis postmenopausal Thai women.

Utennam D, Tungtrongchitr A, Phonrat B, Tungtrongchitr R, Preutthipan S.

Genet Mol Res. 2012 Jan 13;11(1):87-99. doi: 10.4238/2012.January.13.2.

10.

Normal lumbar bone mineral density in optimally treated children and young adolescents with beta-thalassaemia major.

Christoforidis A, Kazantzidou E, Tsatra I, Tsantali H, Koliakos G, Hatzipantelis E, Katzos G, Athanassiou-Metaxa M.

Hormones (Athens). 2007 Oct-Dec;6(4):334-40.

11.

Transforming growth factor-beta1 gene polymorphism, bone turnover, and bone mass in Italian postmenopausal women.

Bertoldo F, D'Agruma L, Furlan F, Colapietro F, Lorenzi MT, Maiorano N, Iolascon A, Zelante L, Locascio V, Gasparini P.

J Bone Miner Res. 2000 Apr;15(4):634-9.

12.

Evidence of association and linkage disequilibrium between a novel polymorphism in the transforming growth factor beta 1 gene and hip bone mineral density: a study of female twins.

Keen RW, Snieder H, Molloy H, Daniels J, Chiano M, Gibson F, Fairbairn L, Smith P, MacGregor AJ, Gewert D, Spector TD.

Rheumatology (Oxford). 2001 Jan;40(1):48-54. Erratum in: Rheumatology (Oxford) 2001 Sep;40(9):1078.

PMID:
11157141
13.

Bone mineral metabolism in adults with beta-thalassaemia major and intermedia.

Dresner Pollack R, Rachmilewitz E, Blumenfeld A, Idelson M, Goldfarb AW.

Br J Haematol. 2000 Dec;111(3):902-7.

PMID:
11122154
14.

Large-scale analysis of association between polymorphisms in the transforming growth factor beta 1 gene (TGFB1) and osteoporosis: the GENOMOS study.

Langdahl BL, Uitterlinden AG, Ralston SH, Trikalinos TA, Balcells S, Brandi ML, Scollen S, Lips P, Lorenc R, Obermayer-Pietsch B, Reid DM, Armas JB, Arp PP, Bassiti A, Bustamante M, Husted LB, Carey AH, Pérez Cano R, Dobnig H, Dunning AM, Fahrleitner-Pammer A, Falchetti A, Karczmarewicz E, Kruk M, van Leeuwen JP, Masi L, van Meurs JB, Mangion J, McGuigan FE, Mellibovsky L, Mosekilde L, Nogués X, Pols HA, Reeve J, Renner W, Rivadeneira F, van Schoor NM, Ioannidis JP; APOSS investigators; DOPS investigators; EPOS investigators; EPOLOS investigators; FAMOS investigators; LASA investigators; ERGO investigators; GENOMOS Study.

Bone. 2008 May;42(5):969-81. doi: 10.1016/j.bone.2007.11.007. Epub 2007 Dec 3.

PMID:
18284942
15.

Evaluation of bone mineral density of the lumbar spine in patients with beta-thalassemia major with dual-energy x-ray absorptiometry and quantitative computed tomography: a comparison study.

Angelopoulos NG, Katounda E, Rombopoulos G, Goula A, Kaltzidou V, Kaltsas D, Ioannis P, Tolis G.

J Pediatr Hematol Oncol. 2006 Feb;28(2):73-8.

PMID:
16462577
16.

A 2-year prospective densitometric study on the influence of Fok-I gene polymorphism in young patients with thalassaemia major.

Dimitriadou M, Christoforidis A, Fidani L, Economou M, Vlachaki E, Athanassiou-Metaxa M, Katzos G.

Osteoporos Int. 2016 Feb;27(2):781-8. doi: 10.1007/s00198-015-3264-1. Epub 2015 Aug 15.

PMID:
26275438
17.

Relationship between serum TGF-β1, OPG levels and osteoporotic risk in native Chinese women.

Xie GQ, Lei DD, He HB, Gong JJ, Chen C, Chen P, Zhang H, Luo XH, Liao EY, Wu XP.

Clin Chim Acta. 2013 Aug 23;423:116-21. doi: 10.1016/j.cca.2013.04.019. Epub 2013 May 2.

PMID:
23643930
18.

Bone mineral density in children and young adults with beta-thalassemia trait.

Mahachoklertwattana P, Chuansumrit A, Choubtum L, Sriphrapradang A, Sirisriro R, Rajatanavin R.

J Pediatr Endocrinol Metab. 2002 Nov-Dec;15(9):1531-5.

PMID:
12503861
19.

Association of estrogen receptor alpha and collagen type I alpha 1 gene polymorphisms with bone mineral density in postmenopausal women.

Erdogan MO, Yıldız H, Artan S, Solak M, Taşcıoğlu F, Dündar U, Eser B, Colak E.

Osteoporos Int. 2011 Apr;22(4):1219-25. doi: 10.1007/s00198-010-1312-4. Epub 2010 Jun 8.

PMID:
20532479
20.

Bone mineral density and its correlation with clinical and laboratory factors in chronic peritoneal dialysis patients.

Ersoy FF, Passadakis SP, Tam P, Memmos ED, Katopodis PK, Ozener C, Akçiçek F, Camsari T, Ateş K, Ataman R, Vlachojannis JG, Dombros AN, Utaş C, Akpolat T, Bozfakioğlu S, Wu G, Karayaylali I, Arinsoy T, Stathakis PC, Yavuz M, Tsakiris JD, Dimitriades CA, Yilmaz ME, Gültekin M, Karayalçin B, Yardimsever M, Oreopoulos DG.

J Bone Miner Metab. 2006;24(1):79-86.

PMID:
16369903

Supplemental Content

Support Center